Literature DB >> 33445676

PKC Regulates YAP Expression through Alternative Splicing of YAP 3'UTR Pre-mRNA by hnRNP F.

Wing-Keung Chu1, Li-Man Hung1,2,3, Chun-Wei Hou1, Jan-Kan Chen1,4.   

Abstract

The Yes-associated protein (YAP) is a transcriptional co-activator that plays critical roles in organ development and tumorigenesis, and is verified to be inhibited by the Hippo signaling pathway. In the present study, we show that the YAP 3'UTR is alternatively spliced to generate a novel 950 bp 3'UTR mRNA from the full length 3'UTR region (3483 bp) in human cancer cells. The ratio of full length 3'UTR YAP mRNA to alternatively spliced 3'UTR YAP mRNA is up-regulated by exposure of the cells to PKC inhibitor chelerythrine chloride. Further study using luciferase reporter assay showed that the expression of the alternatively spliced 3'UTR mRNA is much lower compared with the full length 3'UTR mRNA, suggesting that alternatively spliced 3'UTR YAP mRNA may have a shorter half-life than full length 3'UTR mRNA. Interestingly, PKC represses YAP 3'UTR-mediated mRNA stability is dependent on a splicing factor, hnRNP F. Activation of PKC induces nuclear translocation of cytosolic hnRNP F. Ectopic expression of hnRNP F enhances YAP 3'UTR splicing. Our results suggest that hnRNP F regulates YAP 3'UTR-mediated mRNA stability in an alternative splicing-dependent manner, and PKC regulated YAP expression is dependent on nuclear translocation of hnRNP F in human cancer cell lines.

Entities:  

Keywords:  3′UTR; PKC; alternative splicing; hnRNP F

Mesh:

Substances:

Year:  2021        PMID: 33445676      PMCID: PMC7828143          DOI: 10.3390/ijms22020694

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  33 in total

Review 1.  The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology?

Authors:  B Conne; A Stutz; J D Vassalli
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

2.  Heterogeneous Nuclear Ribonucleoprotein F Stimulates Sirtuin-1 Gene Expression and Attenuates Nephropathy Progression in Diabetic Mice.

Authors:  Chao-Sheng Lo; Yixuan Shi; Isabelle Chenier; Anindya Ghosh; Chin-Han Wu; Jean-Francois Cailhier; Jean Ethier; Jean-Baptiste Lattouf; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  Diabetes       Date:  2017-04-19       Impact factor: 9.461

3.  Activated YAP causes renal damage of type 2 diabetic nephropathy.

Authors:  R Ma; J-M Ren; P Li; Y-J Zhou; M-K Zhou; Z Hu; X-Y Xiao
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-01       Impact factor: 3.507

4.  Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

Authors:  Chi-Ling Chen; Hwai-I Yang; Wei-Shiung Yang; Chun-Jen Liu; Pei-Jer Chen; San-Lin You; Li-Yu Wang; Chien-An Sun; Sheng-Nan Lu; Ding-Shin Chen; Chien-Jen Chen
Journal:  Gastroenterology       Date:  2008-04-04       Impact factor: 22.682

5.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.

Authors:  Bin Zhao; Xiaomu Wei; Weiquan Li; Ryan S Udan; Qian Yang; Joungmok Kim; Joe Xie; Tsuneo Ikenoue; Jindan Yu; Li Li; Pan Zheng; Keqiang Ye; Arul Chinnaiyan; Georg Halder; Zhi-Chun Lai; Kun-Liang Guan
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

Review 6.  Diabetes and Cancer: a Review of Current Knowledge.

Authors:  J Wojciechowska; W Krajewski; M Bolanowski; T Kręcicki; T Zatoński
Journal:  Exp Clin Endocrinol Diabetes       Date:  2016-05-24       Impact factor: 2.949

7.  Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.

Authors:  Lars Zender; Mona S Spector; Wen Xue; Peer Flemming; Carlos Cordon-Cardo; John Silke; Sheung-Tat Fan; John M Luk; Michael Wigler; Gregory J Hannon; David Mu; Robert Lucito; Scott Powers; Scott W Lowe
Journal:  Cell       Date:  2006-06-30       Impact factor: 41.582

8.  The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis.

Authors:  Xiao Zhang; Yongxia Qiao; Qi Wu; Yan Chen; Shaowu Zou; Xiangfan Liu; Guoqing Zhu; Yinghui Zhao; Yuxin Chen; Yongchun Yu; Qiuhui Pan; Jiayi Wang; Fenyong Sun
Journal:  Nat Commun       Date:  2017-05-05       Impact factor: 14.919

9.  The prognostic value of YAP1 on clinical outcomes in human cancers.

Authors:  Ying Wu; Yanshen Hou; Peng Xu; Yujiao Deng; Kang Liu; Meng Wang; Tian Tian; Cong Dai; Na Li; Qian Hao; Dingli Song; Ling Hui Zhou; Zhijun Dai
Journal:  Aging (Albany NY)       Date:  2019-10-15       Impact factor: 5.682

10.  Tubular Deficiency of Heterogeneous Nuclear Ribonucleoprotein F Elevates Systolic Blood Pressure and Induces Glycosuria in Mice.

Authors:  Chao-Sheng Lo; Kana N Miyata; Shuiling Zhao; Anindya Ghosh; Shiao-Ying Chang; Isabelle Chenier; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  Sci Rep       Date:  2019-10-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.